STOCK TITAN

Nippon Shokubai and Arkema: a Strategic Partnership to Mass-produce LiFSI Electrolyte Salts for a European Battery Supply Chain

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary

Nippon Shokubai and Arkema are collaborating to initiate feasibility studies for a joint venture aimed at constructing a facility to produce LiFSI ultrapure electrolyte salts, essential for electric vehicle batteries. This project, set for completion by end-2025 at Arkema’s Pierre-Bénite site in France, aims to enhance battery performance, including power, stability, and charging efficiency. By leveraging Arkema's fluorochemical expertise and Nippon Shokubai's production capabilities, the partnership seeks to address the rising demand for advanced battery materials, supporting the European battery value chain.

Positive
  • Launch of feasibility studies for a joint venture with Nippon Shokubai to produce LiFSI electrolyte salts.
  • Project aims to enhance battery performance, including power and charging efficiency.
  • Set to support the European battery value chain and carbon-neutral mobility initiatives.
Negative
  • None.

COLOMBES, France--(BUSINESS WIRE)-- Regulatory News:

Nippon Shokubai and Arkema (Paris:AKE) are joining forces to launch feasibility studies and establish a joint venture for the construction of an industrial plant for the production of LiFSI (Lithium bis(fluorosulfonyl)imide) ultrapure electrolyte salts, a key component of battery cells for electric mobility.

Ultrapure and high performance LiFSI electrolyte salts, a key component of car battery cells, will speed up the development of new electrolyte formulations for the next generations of batteries, including semi-solid and solid state batteries, by significantly increasing their power, stability, cycle life and recyclability, while reducing charging time in high or low temperature conditions.

This industrial project will support the development of the European battery value chain and participate in the global need for carbon-neutral mobility.

Combining Arkema’s fluorochemicals expertise and Nippon Shokubai’s unique know-how in the industrial-scale production of high-purity LiFSI, both partners have joined forces in a strategic partnership that has led to the development of an innovative and integrated process. Based on this cutting-edge patented technology, a LiFSI fluorinated pilot production line has been installed on the Pierre-Bénite site and successfully came on stream in 2021.

To support the exponential growth in demand for battery cell materials, Arkema and Nippon Shokubai are taking a step forward by launching feasibility studies and establishing a joint venture to enable the mass-production of LiFSI electrolyte salts at Arkema’s Pierre-Bénite site in France by end-2025.

About Nippon Shokubai Co., Ltd.:
Since 1941, Nippon Shokubai has grown up its business with unique catalyst technology. Nippon Shokubai has supplied, for example, ethylene oxide, acrylic acid, automobile catalysts, process catalysts and so on. Among all, our global market share of superabsorbent polymers is the largest in the world now (according to Nippon Shokubai research). Nippon Shokubai is a global chemical company operating under its corporate mission "TechnoAmenity – Providing prosperity and comfort to people and society, with our unique technology."

Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in Specialty Materials, the Group is structured into 3 complementary, resilient and highly innovative segments dedicated to Specialty Materials -Adhesive Solutions, Advanced Materials, and Coating Solutions- accounting for some 85.5% of Group sales in 2021, and a well-positioned and competitive Intermediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, among other things, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of around €9.5 billion in 2021, and operates in some 55 countries with 20,200 employees worldwide.

Follow us on:
Twitter.com/Arkema_group
Linkedin.com/company/arkema

Investor relations contacts

Béatrice Zilm, +33 (0)1 49 00 75 58, beatrice.zilm@arkema.com

Peter Farren, +33 (0)1 49 00 73 12, peter.farren@arkema.com

Mathieu Briatta, +33 (0)1 49 00 72 07, mathieu.briatta@arkema.com

Caroline Chung, +33 (0)1 49 00 74 37, caroline.chung@arkema.com

Media contacts

Gilles Galinier, +33 (0)1 49 00 70 07, gilles.galinier@arkema.com

Anne Plaisance, +33 (0)6 81 87 48 77, anne.plaisance@arkema.com

Source: Arkema

ARKEMA S/ADR

OTC:ARKAY

ARKAY Rankings

ARKAY Latest News

ARKAY Stock Data

7.78B
74.63M
0.01%
Specialty Chemicals
Basic Materials
Link
United States of America
Colombes